SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-09-001077
Filing Date
2009-02-20
Accepted
2009-02-20 09:17:09
Documents
8
Period of Report
2009-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. b74343ape8vk.htm 8-K 14417
2 EX-5.1 OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C. b74343apexv5w1.htm EX-5.1 9489
3 EX-10.1 PLACEMENT AGENT AGREEMENT, DATED FEBRUARY 19, 2009. b74343apexv10w1.htm EX-10.1 168440
4 EX-10.2 FORM OF WARRANT TO PURCHASE SHARES OF ARIAD PHARMACEUTICALS, INC. COMMON b74343apexv10w2.htm EX-10.2 55133
5 EX-10.3 FORM OF SUBSCRIPTION AGREEMENT BETWEEN ARIAD PHARMACEUTICALS, INC. AND E b74343apexv10w3.htm EX-10.3 63122
6 EX-99.1 PRESS RELEASE DATED FEBRUARY 20, 2009. b74343apexv99w1.htm EX-99.1 6485
7 GRAPHIC b74343apb7434301.gif GRAPHIC 2913
8 GRAPHIC b74343apb7434302.gif GRAPHIC 1423
  Complete submission text file 0000950135-09-001077.txt   324879
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21696 | Film No.: 09623270
SIC: 2836 Biological Products, (No Diagnostic Substances)